Are you Dr. Kelmendi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 George St
Ste 901
New Haven, CT 06511Phone+1 203-785-2095
Summary
- Dr. Benjamin Kelmendi, MD is a board certified psychiatrist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2011 - 2015
University of Vermont College of MedicineClass of 2011
Certifications & Licensure
CT State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. Start of enrollment: 2024 May 01
Publications & Presentations
PubMed
- 154 citationsBrain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.Gonzalo Laje, Níall Lally, Daniel C. Mathews, Nancy E. Brutsche, Anat Chemerinski
Biological Psychiatry. 2012-12-01 - 80 citationsPTSD: from neurobiology to pharmacological treatmentsBenjamin Kelmendi, Thomas G. Adams, Stephanie Yarnell, Steven M. Southwick, Chadi G. Abdallah
European Journal of Psychotraumatology. 2016-11-08 - 134 citationsKETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, Irina Esterlis, Gerard Sanacora
Depression and Anxiety. 2016-04-06
Authored Content
- Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018
- Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018
Press Mentions
Changing Lives with Psychedelics: How Connecticut Researchers Are Using Magic Mushrooms to Help People Overcome Depression, OCDNovember 17th, 2022- NIH: It’s Time to Make Your Mark on the Renaissance of Medicinal PsychedelicsJune 2nd, 2021
- Global Psychedelic Therapeutics Market Is Projected to Grow at an Annualized Rate of ~15%, Till 2030January 12th, 2021
